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Background: Although TAVI is becoming a mature technique, the impact
of gender difference remains unclear.
Methods: TAVI patients were included prospectively in a dedicated data-
base. The proportion of female patients (131) was similar to male (129). The
Edwards valve (85.4%) and CoreValve (14.6%) were used via the transfem-
oral (65.0%), subclavian (3.1%) or transapical approach (31.9%). All events
were defined by the VARC criteria.
Results: Age was similar (83.1±6.3 years), but women had less coronary
and peripheral disease and previous cardiac surgery, and higher ejection frac-
tion with a lower EuroSCORE (22.3±9.0 vs 26.2±13.0%, p=0.005). Minimal
femoral size (7.74±1.03 vs 8.55±1.34mm, p<0.001), annulus size (20.9±1.4 vs
22.9±1.7mm, p<0.001) and valve size (23.9±1.6 vs 26.3±1.5mm, p<0.001)
were smaller in women. Device success was similar (90.8 vs 88.4%, p=0.516)
despite increased iliac complication (9.0 vs 2.5%, p=0.030). Kaplan-Meier
survival at 1-year was 76% (95%CI, 72-80%) for women vs 65% (95%CI, 60-
69%) for men (log-rank p=0.022).
By multivariate analysis, male gender (HR 1.798: 1.004-3.215, p=0.048),
previous cardiac surgery (HR 2.299: 1.219-4.336, p=0.010), post-procedural
aortic regurgitation (HR 2.261: 1.308-3.909, p=0.004), Transfusion (HR
2.474: 1.319-4.640, p=0.005), acute kidney injury (HR 6.907: 3.085-15.465,
p<0.001), and conversion to surgery (HR 5.147: 1.428-18.550, p=0.012) were
identified as the predictors for long-term mortality.
Conclusions: Female patients have better baseline clinical characteristics
and better survival, and are also identified as an independent predictor of long-
term survival in the TAVI cohort.
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Background: Transcatheter aortic valve implantation (TAVI) is a growing
cardiac intervention, using ionising radiation with deterministic and stochastic
effects for the patient as well as for the medical heart team. Operator radiation
depends on numerous factors, such as distance to the source, fluoroscopy time,
and X ray tube angulation. Lead protection is routinely used for coronary
angiography, but is less suitable for use during TAVI, and areas such as the
hands and eyes are not systematically protected. We aimed to quantify the
radiation dose received by the heart team members during TAVI and evaluate
the role of the position of each member.
Methods: Operator radiation was evaluated by means of small dosimeters
located on the outside of the lead protection at shoulder, knee and hip. We also
measured radiation at the level of the eyes and hands, using small dosimeters that
could be mounted on glasses and rings. The whole team was equipped (3 sur-
geons, 2 interventional cardiologists, 1 nurse and 1 echocardiographer).
Results: 12 TAVI were performed between February and May 2010
(4 apical and 8 femoral access). The most exposed area was the knee for all
members of the team. The most exposed member was the surgeon standing
closest to the X-ray tube, who received a significantly higher dose than all
other team members, and for all areas measured. During a difficult implanta-
tion procedure, we observed an alarmingly high dose at the level of the hand
(2000 μSv) and the eyes (499 μSv) for this surgeon, who does not have pro-
tective glasses and gloves adapted for this procedure at his disposition.
Conclusion: A higher radiation dose was received by the surgeon closest
to the X-ray tube during TAVI. Further to this study, we modified our proce-
dure to reduce the radiation dose as much as possible for the medical team,
with systematic use of lead protection and glasses, and identification of the
fluoroscopy period.
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Objectives: We recently demonstrated the presence of tissue factor (TF),
the main contributor to atherosclerotic plaque thrombogenicity, and thrombin
in diseased valve leaflets. TF may be involved in the mineralization process
of aortic valves by enhancing the generation of the pro-inflammatory
osteopontin (OSP) N-half through thrombin induction. To strengthen our
hypothesis, we evaluated TF expression by cultured valve interstitial cells
(VICs) and studied their ability to generate thrombin in vitro.
Methods: VICs were obtained from explanted aortic valves after collage-
nase digestion. TF activity was measured with a commercial chromogenic
assay under basal conditions and after stimulation with TNF- (10-50 ng/ml;
16h). Thrombin generation capacities of VICs were analyzed using a Cali-
brated Automated Thrombogram assay. A dedicated software program
enabled the calculation of thrombin generation over time. The area under the
curve (ETP) represents the total amount of thrombin generated. The lag time
is the time needed to achieve an explosive burst of thrombin.
Results: The isolated VICs express active TF. Basal TF antigen and
activity varied among valves and were dose-dependently increased after stim-
ulation with TNF-. VICs were able to generate thrombin in vitro, propor-
tional to the amount of cells used for the experiments. TNF- stimulation led
to a shorter lag time (12.6 min vs 10.8 min basal vs stimulated conditions) and
increased both the maximal and total concentration of generated thrombin
(peak: 141nM vs 116 nM; ETP:1034 nM/min vs 1179 nM/min; stimulated vs
unstimulated).
Conclusion: We showed here for the first time that VICs express active TF
and are able to generate thrombin in vitro. TF expression by VICs can be
induced by TNF- stimulation. The concentration of thrombin generated is
proportional to the amount of cells and TF activity. These results strengthen
our hypothesis that TF may play a role in aortic valve mineralization through
thrombin generation.
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Background: Pulmonary hypertension (PHT) in patients with severe aortic
stenosis (AS) is associated with increased morbidity and mortality. In asymp-
tomatic patients, the additive value of exercise (Ex) PHT is unexplored. We
aimed to identify the determinants and impact on outcome of ExPHT in
asymptomatic patients with severe AS.
Method and results: Asymptomatic patients with severe AS (n=106) and
preserved left ventricular (LV) function were prospectively referred to exer-
cise stress echo. Resting and ExPHT were defined as a systolic pulmonary
arterial pressure (SPAP) >50 mmHg and >60 mmHg, respectively. Ex PHT
was more frequent than resting PHT (55% vs. 6%, p<0.0001). Patients with
ExPHT were more frequently male (p=0.035), had significant higher mean
aortic gradient (p=0.04) and longer diastolic filling time (p=0.015) than those
without ExPHT. ExSPAP was correlated with resting aortic mean pressure
gradient and peak aortic velocity (r=0.49 and r=0.48, both p=0.01), with LV
diastolic filling time (r=0.54, p=0.003) and the Ex-induced changes in E/Ea
ratio (r=–0.53, p=0.007). Multivariate logistic regression analysis showed that
only Ex-induced changes in E/Ea ratio (p=0.02) and resting peak aortic
velocity (p=0.007) were independently associated with ExSPAP.
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ExPHT was associated with reduced cardiac event-free survival (27±7%
vs. 53±9%, p=0.02). In multivariate Cox proportional hazard model, the inde-
pendent predictors of events were resting E/Ea ratio (p=0.01), aortic peak
velocity (p<0.0001), indexed left atrium area (p=0.005), LV global longitu-
dinal strain (p=0.04) and ExPHT (hazard ratio=1.9, p=0.04). When adding Ex-
induced changes in aortic mean gradient to the multivariate model, ExPHT
remained an independent predictor outcome (p=0.033).
Conclusion: In asymptomatic patients with severe AS, the main determinants
of ExPHT are the severity of AS and the Ex-induced changes in LV filling pres-
sure. ExPHT is associated with 2-fold increased risk of cardiac events.
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The mitral stenosis (MS) is the most common valvular disease in the
Maghreb; young women of procreation age are most concerned.
Percutaneous mitral commissurotomy (PMC) has changed the prognosis of
symptomatic MS of pregnant woman.
We report our experience on eighty-three patients requiring PMC during
the third trimester of pregnancy, between March 1998 and May 2010.
Their mean age was 29±4, 9 years; the presumed age of pregnancy was
27.5±2.9 weeks of gestation. Fifteen were in New York Heart Association
class II; fifty in class III and eighteen in class IV. Twelve patients with atrial
fibrillation. Wilkins score calculated in all patients with an average 7±2.
No fetal deaths were noted after the procedure. 1 case of stroke, transient.
No abortions occurred following the procedure.
We report a maternal death fifteen days after delivery. All patients have
improved after the surgery at least one class of NYHA.
Mitral surface area and hemodynamic parameters improved significantly
after PMC; mean left atrial pressure fell from 30±6.3 to 12.2±7 mmHg, mean
transmitral gradient from 21±7.2 to 6.1±3.2 mmHg and mitral valve area from
0.8±0.15 to 2.15±0.2 cm2.
During pregnancy the PMC is the treatment of choice of MS must be per-
formed by an experienced team because the angle of the trans septal puncture
is subject to changes in pregnant women.
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Objectives: This study analyzed the association between pre-operative rest
echocardiography and the 6-month post-operative left ventricular ejection
fraction (LVEF) in organic mitral regurgitation (MR).
Background: LV end-systolic diameter is the marker of LV function in
patients with organic MR associated to survival and post-operative EF, but
still some patients have nowadays a depressed post-operative LV EF despite
correct diameters.
Methods: 88 patients (62.6±1.4 yo) were prospectively recruited. They all
got a complete echocardiography including the assessment of LV-deforma-
tions before the MR repair and all had an echocardiography at 6-month after-
surgery. Exclusion criteria were: coronary artery disease, other organic val-
vular disease, uncontrolled arrhythmia, hemodynamic instability.
Results: The principal parameters not correlated to post-operative LVEF
(0.5±0.08) are displayed in table I. The univariate analysis concluded that: LV
end-systolic diameter (36±0.7 mm, R=–0.34, p=0.009); Left atrial area
(26.4±1.0 cm²; R=–0.37, p=0.011); LV end-diastolic volume (149.9±5.2 ml;
R=–0.31, p=0.019); LV end-systolic volume (52.3±2.5 ml; R=–0.35,
p=0.003); Mitral annulus diameter (37±0.7 mm; R=–0.25; p=0.01). Using a
multivariate linear regression, the GLS/LV end-systolic volume (–4.6±0.3;
p=0.01) and the left atrial diameter (44.7±0.8 mm; p=0.01) were the best pre-
dictor of post-operative LVEF (R²=0.22).
Conclusions: In organic MR, LV end-systolic diameter is a key parameter
to propose surgery. We demonstrated that global longitudinal strain (GLS, %)
normalized for the end-systolic volume is, with the LA size, an important
determinant of post-operative EF.
Table – Main results
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Background: There is uncertainty and debate regarding whether ischemic
mitral regurgitation (MR) is a secondary epiphenomenon resulting from left
ventricular (LV) dysfunction or confers an independent effect on exercise
capacity and outcomes.
Objective: We tested whether ischemic MR negatively impacts exercise
capacity, cardiovascular morbidity and mortality in patients with coronary
artery disease (CAD) and inferior wall motion abnormality patients, indepen-
dent of LV dysfunction.
Methods: Clinical follow-up over 5 years was obtained in 77 patients (age
64±10 years, LVEF 54±11%) with at least mild ischemic MR from CAD and
evidence of inferior wall motion abnormality, who had exercise stress testing
with perfusion imaging within 24 hours of echocardiography. Patients with
active heart failure, ischemia, intrinsic valve disease, pulmonary and vascular
disease were excluded. Exercise capacity (METs, peak double product) was
tested for relation to MR (vena contracta (VC) and jet area), LV size and func-
tion, and pulmonary pressures. Cox proportional hazards analysis assessed
whether MR predicted cardiovascular events, including hospitalization for
heart failure, acute coronary syndrome, and myocardial infarction, and cardio-
vascular (CV) and total mortality.
Results: By multivariate analysis, independent predictors of functional
capacity (METs and peak double product) were MR vena contracta (VC;
r²=0.62, p<0.0001) and LV end-diastolic volume (EDV; r²=0.78, p=0.03). MR
jet area contributed similarly (r²=0.61, p<0.0001). MR VC >2 mm (moderate
ischemic MR) and age were independent predictors of CV events and death
(HR 6.72 for MR, p=0.04).
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mean±SE
Left atrial volume (ml) 44.7±0.8
LV end-diastolic diameter (mm) 55.9±0.9
LVEF (%) 66.2±0.8
LVOT VTI (cm) 17.3±0.5
Mitral inflow E-wave (cm/s) 91.8±5.9
S’ mitral (lateral) (cm/s) 10.4±0.4
Tricuspid maximal velocity (m/s) 2.8±0.1
